Axonics (STU:0I3) Ending Cash Position : €228.6 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Axonics Ending Cash Position?

Axonics's Ending Cash Position for the quarter that ended in Mar. 2024 was €228.6 Mil.

Axonics's quarterly Ending Cash Position declined from Sep. 2023 (€138.0 Mil) to Dec. 2023 (€107.8 Mil) but then increased from Dec. 2023 (€107.8 Mil) to Mar. 2024 (€228.6 Mil).

Axonics's annual Ending Cash Position increased from Dec. 2021 (€195.5 Mil) to Dec. 2022 (€225.5 Mil) but then declined from Dec. 2022 (€225.5 Mil) to Dec. 2023 (€107.8 Mil).

Axonics Ending Cash Position Historical Data

The historical data trend for Axonics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Ending Cash Position Chart

Axonics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

153.97

198.25

195.48

225.47

107.77

Axonics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															224.26	134.15	138.04	107.77	228.59

Axonics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Axonics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	219.021	+	-111.251
	=	107.8

Axonics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	108.123	+	120.47
	=	228.6

Axonics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Axonics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Axonics (STU:0I3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (STU:0I3) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AXNX:USA 0I3:Germany

Address

26 Technology Drive, Irvine, CA, USA, 92618

Website

https://www.axonics.com

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.

Axonics (STU:0I3) Headlines

No Headlines